Anaptysbio (ANAB) FCF Margin (2016 - 2026)
Anaptysbio (ANAB) reported FCF Margin of 101.49% for Q1 2026, down 6283.0% on a YoY basis from 1.64% in Q1 2025, and down 177.67% quarter-over-quarter from 130.66% in Q4 2025.
Anaptysbio (ANAB) FCF Margin (2016 - 2026) Analysis & Trends
Anaptysbio has reported FCF Margin for 11 years, with the latest figure at 101.49% in Q1 2026.
- For the quarter ending Q1 2026, FCF Margin fell 6283.0% year-over-year to 101.49%; the trailing twelve-month figure through Mar 2026 stood at 2.55% (up 14117.0% YoY), and the FY2025 full-year result was 8.36%, up 15702.0% from the prior year.
- FCF Margin for Q1 2026 stood at 101.49%, down from 130.66% in the prior quarter.
- The five-year high for FCF Margin was 130.66% in Q4 2025, with the low at 2168.35% in Q1 2022.
- Historically, FCF Margin has averaged 650.8% across 5 years, with a median of 267.74% in 2024.
- The largest YoY upside for FCF Margin was 228833 bps in 2022 against a maximum downside of 203879 bps in 2022.
- Anaptysbio's FCF Margin stood at 216.22% in 2022, then tumbled by 79 bps to 387.31% in 2023, then jumped by 31 bps to 267.74% in 2024, then surged by 149 bps to 130.66% in 2025, then plunged by 178 bps to 101.49% in 2026.
- The last three FCF Margin figures came in at 101.49% (Q1 2026), 130.66% (Q4 2025), and 54.74% (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | -3.98% |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 43.35% |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Anaptysbio | 1.66 Bn | 1.38 Bn | - | -101.49% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -101.49% |
| Dec 31, 2025 | 130.66% |
| Sep 30, 2025 | -54.74% |
| Jun 30, 2025 | -180.94% |
| Mar 31, 2025 | -38.66% |
| Dec 31, 2024 | -267.74% |
| Sep 30, 2024 | -67.50% |
| Jun 30, 2024 | -194.65% |
| Mar 31, 2024 | -519.29% |
| Dec 31, 2023 | -387.31% |
| Sep 30, 2023 | -1,106.12% |
| Jun 30, 2023 | -730.81% |
| Mar 31, 2023 | -1,800.80% |
| Dec 31, 2022 | -216.22% |
| Sep 30, 2022 | -1,364.42% |
| Jun 30, 2022 | -1,995.15% |
| Mar 31, 2022 | -2,168.35% |
| Dec 31, 2021 | -2,504.55% |
| Sep 30, 2021 | -29.19% |
| Jun 30, 2021 | 43.64% |